The current study aimed to evaluate associations between standard pre-diagnostic serum markers of chronic inflammation (CRP, albumin, haptoglobin and leukocytes) and pancreatic cancer risk in the prospective Swedish Apolipoprotein-related MORtality RISk (AMORIS) cohort study. This evidence concerns the gene ALB and familial pancreatic carcinoma.